Stage IV Breast Cancer AJCC v6 and v7
Showing 1 - 25 of 40
Locally Advanced Breast Carcinoma, Metastatic Breast Carcinoma, Recurrent Breast Carcinoma Trial in United States (Laboratory
Active, not recruiting
- Locally Advanced Breast Carcinoma
- +7 more
- Laboratory Biomarker Analysis
- +2 more
-
Duarte, California
- +3 more
Jan 31, 2023
Invasive Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v6 Trial in Puerto Rico, United States
Active, not recruiting
- Invasive Breast Carcinoma
- +3 more
- Bevacizumab
- +4 more
-
Mobile, Alabama
- +525 more
Jan 28, 2023
HER2/Neu Negative, Progesterone Receptor Negative, Progesterone Receptor Positive Trial in United States (procedure, drug,
Active, not recruiting
- HER2/Neu Negative
- +3 more
- Computed Tomography
- +3 more
-
Birmingham, Alabama
- +24 more
Jan 27, 2023
Metastatic Malignant Tumor in the Bone, Stage IV Breast Cancer AJCC v6 and v7, Triple-Negative Breast Carcinoma Trial in
Active, not recruiting
- Metastatic Malignant Neoplasm in the Bone
- +2 more
- Laboratory Biomarker Analysis
- +2 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jan 4, 2023
Blood and Tumor Samples From Advanced or Metastatic Estrogen
Active, not recruiting
- Advanced Breast Carcinoma
- +8 more
- Biopsy
- +2 more
-
Scottsdale, Arizona
- +2 more
Jan 3, 2023
Metastatic Lung Non-Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in
Active, not recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +24 more
- 18F-Fluoromisonidazole
- +4 more
-
La Jolla, California
- +15 more
Jan 3, 2023
BRCA1 Gene Mutation, BRCA2 Gene Mutation, Locally Advanced Solid Tumor Trial in New Brunswick, New York (Laboratory Biomarker
Recruiting
- BRCA1 Gene Mutation
- +19 more
- Laboratory Biomarker Analysis
- Pembrolizumab
-
New Brunswick, New Jersey
- +1 more
Nov 16, 2022
Metastatic Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7 Trial in United States (drug, other, biological)
Suspended
- Metastatic Breast Carcinoma
- Stage IV Breast Cancer AJCC v6 and v7
- Fulvestrant
- +4 more
-
Corona, California
- +6 more
Sep 28, 2022
Malignant Digestive System Tumor, Metastatic Head and Neck Carcinoma, Metastatic Kidney Carcinoma Trial in Houston (procedure,
Recruiting
- Malignant Digestive System Neoplasm
- +12 more
- Computed Tomography
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Metastatic Lung Non-Small Cell Carcinoma Trial in Seattle
Terminated
- Hematopoietic and Lymphoid Cell Neoplasm
- +12 more
- Laboratory Biomarker Analysis
- ROR1 CAR-specific Autologous T-Lymphocytes
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 11, 2022
Metastatic BRCA-Associated Breast Carcinoma, Metastatic Breast Carcinoma, Metastatic Malignant Tumor in the Brain Trial in
Active, not recruiting
- Metastatic BRCA-Associated Breast Carcinoma
- +5 more
- Cisplatin
- +3 more
-
Anchorage, Alaska
- +815 more
Aug 5, 2022
Locally Advanced Unresectable Breast Carcinoma, Metastatic Breast Carcinoma, Stage III Breast Cancer AJCC v7 Trial in United
Suspended
- Locally Advanced Unresectable Breast Carcinoma
- +3 more
- Atezolizumab
- +2 more
-
Phoenix, Arizona
- +57 more
Jul 27, 2022
HER2-Positive Breast Carcinoma, Invasive Breast Carcinoma, Metastatic Malignant Tumor in the Brain Trial in Canada, Korea,
Completed
- HER2-Positive Breast Carcinoma
- +4 more
- Laboratory Biomarker Analysis
- +3 more
-
Birmingham, Alabama
- +301 more
Jun 28, 2022
Breast Adenocarcinoma, Invasive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States (drug, biological, other)
Active, not recruiting
- Breast Adenocarcinoma
- +9 more
- Entinostat
- +4 more
-
Duarte, California
- +4 more
Jul 16, 2022
Advanced Malignant Tumor, Castleman Disease, Digestive System Carcinoma Trial in Houston (biological, other, drug)
Active, not recruiting
- Advanced Malignant Neoplasm
- +38 more
- Bevacizumab
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jul 18, 2022
Androgen Receptor Positive, Estrogen Receptor Negative, HER2/Neu Negative Trial in United States (drug, other, biological)
Active, not recruiting
- Androgen Receptor Positive
- +5 more
- Enobosarm
- +2 more
-
Corona, California
- +6 more
Jun 8, 2022
Breast Adenocarcinoma, HER2/Neu Negative, Invasive Breast Carcinoma Trial in United States (Eribulin Mesylate, Laboratory
Suspended
- Breast Adenocarcinoma
- +4 more
- Eribulin Mesylate
- +3 more
-
Scottsdale, Arizona
- +38 more
May 25, 2022
Collecting Blood Samples From and Without Cancer to Evaluate
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +61 more
- Questionnaire Administration
- Biospecimen Collection
- (no location specified)
Apr 12, 2022
Metastatic Breast Adenocarcinoma, Metastatic HER2-Positive Breast Carcinoma, Recurrent Breast Adenocarcinoma Trial in Canada,
Recruiting
- Breast Adenocarcinoma
- +8 more
- Atezolizumab
- +6 more
-
Birmingham, Alabama
- +667 more
Apr 6, 2022
Breast Adenocarcinoma, Metastatic Triple-Negative Breast Carcinoma, Stage III Breast Cancer AJCC v7 Trial in Jacksonville (drug,
Active, not recruiting
- Breast Adenocarcinoma
- +6 more
- Binimetinib
- +2 more
-
Jacksonville, FloridaMayo Clinic in Florida
Dec 14, 2021
Breast Adenocarcinoma, HER2/Neu Negative, Locally Advanced Breast Carcinoma Trial in South Africa, United States (Entinostat,
Active, not recruiting
- Breast Adenocarcinoma
- +9 more
- Entinostat
- +3 more
-
Birmingham, Alabama
- +662 more
Oct 18, 2021
Estrogen Receptor-positive Breast Cancer, HER2/Neu Negative, Stage IV Breast Cancer AJCC v6 and v7 Trial in United States
Active, not recruiting
- Estrogen Receptor-positive Breast Cancer
- +2 more
- Palbociclib
- +4 more
-
Anchorage, Alaska
- +446 more
Sep 17, 2021
Collecting, Analyzing, and Storing Samples From Metastatic,
Terminated
- Estrogen Receptor Negative
- +4 more
- Cytology Specimen Collection Procedure
- +3 more
-
Seattle, Washington
- +1 more
Sep 23, 2021
Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v7, Stage IIIA Breast Cancer AJCC v7 Trial in United States (Endoxifen
Active, not recruiting
- Recurrent Breast Carcinoma
- +5 more
- Endoxifen Hydrochloride
- +3 more
-
Mobile, Alabama
- +566 more
Sep 1, 2021